Optimal First-Line Therapy for Acute Low-Tone Sensorineural Hearing Loss
Open Access
- 10 October 2021
- journal article
- research article
- Published by The Korean Audiological Society in Journal of Audiology and Otology
- Vol. 25 (4) , 209-216
Abstract
Background and Objectives: We aimed to analyze treatment outcomes following different initial management approaches and confirm treatment regimens for acute low-tone sensorineural hearing loss (ALHL) that would yield the best results.Subjects and Methods: We retrospectively analyzed the medical records of 106 patients with ALHL who visited a university hospital’s otology clinic from March 2013 to June 2019. Pure-tone averages at the initial visit and at 2 and 4 weeks after the initial visit were evaluated.Results: Forty-nine patients were enrolled in this study; of them, 41 (83.7%) exhibited complete recovery (CR) at 2 weeks and 43 (87.8%) exhibited CR at 1 month after the initial visit. Regression analysis revealed that CR at 2 weeks after the initial visit was associated with diuretic use [Exp(B): 10.309, 95% confidence interval (CI): 1.007-100]. An initial daily low-dose steroid use was marginally significant [Exp(B): 1.042, 95% CI: 0.997-1.092; p=0.066]. Isolated diuretic use [Exp(B): 25.641, 95% CI: 1.121-90.909; p=0.039] was an independent, good prognostic factor at 1 month after the initial visit. However, other treatment regimens did not affect the final results.Conclusions: A combination of initial daily administration of ≤30 mg prednisolone plus diuretics was sufficient as the first-line treatment for ALHL. High-dose steroids and salvage intratympanic steroid injections can be applied as a second choice; however, the predicted outcome would not be good in that case.Keywords
Funding Information
- National Research Foundation of Korea (2017R1C1B5017839)
- Ministry of Education
This publication has 28 references indexed in Scilit:
- A Comparison of the Short-Term Outcome in Patients with Acute Low-Tone Sensorineural Hearing LossORL, 2010
- Vestibular-Evoked Myogenic Potential in the Prediction of Recovery From Acute Low-Tone Sensorineural Hearing LossEar & Hearing, 2010
- Prognosis of sudden low-tone loss other than acute low-tone sensorineural hearing lossActa Oto-Laryngologica, 2009
- Use of intratympanic dexamethasone for the therapy of low frequency hearing lossEuropean Archives of Oto-Rhino-Laryngology, 2008
- Prognosis of low-tone sudden deafness – does it inevitably progress to Meniere's disease?Acta Oto-Laryngologica, 2008
- Metabolic complications associated with use of thiazide diureticsJournal of the American Society of Hypertension, 2007
- Effect of Corticosteroids or Diuretics in Low-Tone Sensorineural Hearing LossORL, 2006
- Vestibular Evoked Myogenic Potentials in Acute Low‐Tone Sensorineural Hearing LossThe Laryngoscope, 2004
- Short-Term Outcome and Prognosis of Acute Low-Tone Sensorineural Hearing Loss by Administration of SteroidORL, 2002
- Acute Low-Tone Sensorineural Hearing Loss Without VertigoJAMA Otolaryngology–Head & Neck Surgery, 1994